Home/Filings/4/0001104659-23-032337
4//SEC Filing

WEISS MICHAEL S 4

Accession 0001104659-23-032337

CIK 0001001316other

Filed

Mar 13, 8:00 PM ET

Accepted

Mar 14, 5:00 PM ET

Size

5.3 KB

Accession

0001104659-23-032337

Insider Transaction Report

Form 4
Period: 2023-03-12
WEISS MICHAEL S
DirectorCEO
Transactions
  • Award

    COMMON STOCK

    2023-03-12+985,00011,973,021 total
Footnotes (2)
  • [F1]Reflects a grant of restricted shares, which will vest and become non-forfeitable based on the Company's total shareholder return relative to the Nasdaq Biotechnology Index over a one-year to five-year period, provided that the Reporting Person remains an employee, director and/or consultant of the Company through each vesting date.
  • [F2]Includes shares of restricted Common Stock, which vest over various time periods.

Issuer

TG THERAPEUTICS, INC.

CIK 0001001316

Entity typeother

Related Parties

1
  • filerCIK 0001038977

Filing Metadata

Form type
4
Filed
Mar 13, 8:00 PM ET
Accepted
Mar 14, 5:00 PM ET
Size
5.3 KB